Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00900575 | Cervical Cancer Detection Using Optical Spectroscopy | recruiting | N/A | 350 | Duke UniversityOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT04107181 | Pilot Study for Speculum Free Cervical Cancer Screening(Calla) | recruiting | N/A | 305 | Duke UniversityOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT05977621 |
| Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking((TRUS)) |
| recruiting |
| — |
| 17 |
| Duke UniversityOTHER |
| 1 |
| Mar 6, 2026 |
| clinicaltrials |
| NCT03853915 | FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)(HPVDNA02) | recruiting | N/A | 64 | University Health Network, TorontoOTHER | 1 | Mar 5, 2026 | clinicaltrials |
| NCT04075305 | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study(MOMENTUM) | recruiting | — | 8,000 | UMC UtrechtOTHER | 9 | Mar 5, 2026 | clinicaltrials |
| NCT04857528 | Detecting HPV DNA in Anal and Cervical Cancers | recruiting | — | 20 | University of ChicagoOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06268665 | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | recruiting | Phase 2 | 86 | University of California, DavisOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06525740 | Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery | recruiting | Phase 4 | 140 | Mayo ClinicOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06935344 | Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study(PROVE) | recruiting | — | 1,300 | Catholic University of the Sacred HeartOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07121738 | A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer(HEAL-GYN) | recruiting | N/A | 64 | AdventHealthOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07447050 | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial | recruiting | Phase 2 | 24 | University of California, IrvineOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06369155 | Azenosertib in Uterine Serous Carcinoma: Biomarker Study | recruiting | Phase 2 | 25 | Joyce Liu, MDOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07372248 | Thermal Artifact in Patients Undergoing Conization: A Clinical Study | recruiting | N/A | 150 | Saglik Bilimleri UniversitesiOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07435623 | Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study | recruiting | — | 300 | Tata Memorial HospitalOTHER_GOV | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07443475 | Electrochemotherapy for Recurrent Vulvar Cancer | recruiting | Phase 2 | 13 | Institute of Oncology LjubljanaOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT05574673 | Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype(HERO) | recruiting | — | 1,000 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07033819 | Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib | recruiting | Phase 2 | 48 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07435376 | Intra-lesional Tumor Boost for Bulky Cervical Cancer(INTLECTUAL) | recruiting | Phase 2 | 17 | Seoul National University Bundang HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07439497 | Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer(DEHIM_CCRT) | recruiting | Phase 2 | 34 | Samsung Medical CenterOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07225530 | Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)((iSTAR)) | recruiting | N/A | 600 | Columbia UniversityOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07433283 | Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 54 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT07416630 | Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients | recruiting | N/A | 30 | Institute of Oncology LjubljanaOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT05974150 | Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring | recruiting | — | 25 | Carevive Systems, Inc.INDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06572735 | Study on the Relative Dose Intensity of PARP Inhibitors in Real-life on a Population of Patients Over 70 Years With Advanced Ovarian Cancer(PARIB-OLD-PRO²) | recruiting | — | 50 | Hospices Civils de LyonOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06264167 | NODE (groiN ultrasOunD cancEr)(NODE) | recruiting | N/A | 30 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Feb 20, 2026 | clinicaltrials |
| NCT06644846 | Spatially Fractionated Radiation Treatment for Gynaecological Cancers | recruiting | N/A | 20 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 20, 2026 | clinicaltrials |
| NCT04997096 | Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy | recruiting | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT06305962 | 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors | recruiting | Early Phase 1 | 30 | Radiopharm Theranostics, LtdINDUSTRY | 1 | Feb 19, 2026 | clinicaltrials |
| NCT06513065 | Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)(HIPEC-PMP) | recruiting | Phase 3 | 176 | University of SouthamptonOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07410494 | Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors(SELECT-CAR-NK) | recruiting | Phase 1 / Phase 2 | 85 | Essen BiotechOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07410676 | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors(EBNK-ST-001) | recruiting | Phase 1 / Phase 2 | 83 | Essen BiotechOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT03624244 | Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS)(BFR-ESS) | recruiting | Phase 2 | 40 | Centre Leon BerardOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03997110 | Palliative Radiation for Advanced Cervical Cancer(RAPPAL) | recruiting | N/A | 230 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)(IT-TCP POS) | recruiting | N/A | 300 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407959 | Screening and Staging of Benign vs Malignant Pelvic Abnormalities | recruiting | — | 60 | Mayo ClinicOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT03862677 | Determining Prognostic Immune Markers in Patients With Ovarian Cancer(IMPrOVE) | recruiting | — | 300 | Leiden University Medical CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05103683 | First in Human Study of TORL-1-23 in Participants With Advanced Cancer | recruiting | Phase 1 | 90 | TORL Biotherapeutics, LLCINDUSTRY | 2 | Feb 13, 2026 | clinicaltrials |
| NCT05827523 | Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)(FOCUS / KOV-04) | recruiting | Phase 3 | 520 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 13, 2026 | clinicaltrials |
| NCT06562647 | SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors | recruiting | N/A | 2 | Cell Origin Biotech (Hangzhou) Co., Ltd.INDUSTRY | 1 | Feb 13, 2026 | clinicaltrials |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation(GUARDIAN-101) | recruiting | Phase 1 | 90 | Clasp Therapeutics, Inc.INDUSTRY | 1 | Feb 13, 2026 | clinicaltrials |
| NCT05448365 | Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid | recruiting | N/A | 60 | Lo.Li.Pharma s.r.lINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT05774561 | Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring | recruiting | — | 480 | The Institute of Molecular and Translational Medicine, Czech RepublicOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07214584 | Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy | recruiting | — | 55 | University of FloridaOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07397624 | Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer(ESG-ENDO) | recruiting | — | 74 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06071286 | SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS(SPEED) | recruiting | N/A | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT05914974 | Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies | recruiting | — | 120 | University Hospital TuebingenOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT06128304 | ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services(ACCESS) | recruiting | N/A | 2,436 | University of California, San DiegoOTHER | 2 | Feb 10, 2026 | clinicaltrials |
| NCT07217262 | Proactive Costs of Care Study(PCOC) | recruiting | N/A | 36 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 10, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Mar 6, 2026source: clinicaltrials